8.87

4.11% -0.38

Aspire Biopharma Holdings Inc (ASBP)

Overview News Price History Discussions Forecast

Aspire Biopharma Holdings Inc stock is traded at $8.87, with a volume of 42,775. It is down -4.11% in the last 24 hours and up +25.99% over the past month. Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Previous Close:

$9.25

Open:

$9.25

24h Volume:

42,775

Relative Volume:

0.15

Market Cap:

$12.44M

Revenue:

$34,600

Net Income/Loss:

$-11.76M

P/E Ratio:

-0.0578

EPS:

-153.5649

Net Cash Flow:

$-6.21M

1W Performance:

+4.23%

1M Performance:

+25.99%

6M Performance:

-77.60%

1Y Performance:

-98.64%

1-Day Range:

$8.80

$9.50

1-Week Range:

$8.49

$9.50

52-Week Range:

$3.309

$659.88

Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile

Name

Aspire Biopharma Holdings Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

561-704-8527

Address

23150 FASHION DRIVE, SUITE 232, ESTERO

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

ASBP's Discussions on Twitter

Compare ASBP vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ASBP Aspire Biopharma Holdings Inc	8.87	10.97M	34,600	-11.76M	-6.21M	-153.56
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Aspire Biopharma Holdings Inc Stock (ASBP) Latest News

Aug 19, 2026

Form 8K Aspire Biopharma Holdings Inc For: 19 August By Investing.com - Investing.com Nigeria

Aug 19, 2026

Aug 18, 2026

ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits

Aug 18, 2026

Aug 17, 2026

LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits

Aug 17, 2026

Aspire Biopharma (ASBP) Holds Steady at $7.91 with Key Support and Resistance in FocusParabolic SAR - Vinanet

Aug 17, 2026

Aspire (ASBPW) Retreats -0.54% — Bears Take Control Below $0.02 2026-08-17Arms Index - vinanet.vn

Aug 17, 2026

Aug 15, 2026

Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire

Aug 15, 2026

Aug 14, 2026

S&R Associates Advises MiddleGround Capital on Sale of Dura Driver Control Systems to Aspire Biopharma Holdings - SCC Online

Aug 14, 2026

Aug 13, 2026

Aspire Biopharma (NASDAQ: ASBP) slashes H1 2026 loss and rebuilds equity - Stock Titan

Aug 13, 2026

Aspire Biopharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Aspire Biopharma (ASBP) Gains 1.82% to $7.26, Approaches Key Resistance ZoneBackspread Trade - vinanet.vn

Aug 13, 2026

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th - ACCESS Newswire

Aug 13, 2026

Aspire Biopharma (ASBP) Earnings Date and Reports 2026 - MarketBeat

Aug 13, 2026

Aug 12, 2026

Aspire Biopharma (ASBPW) Warrant Rises 5.00% to $0.02, Trapped in Tight Trading RangeAccumulation Line - vinanet.vn

Aug 12, 2026

Aug 11, 2026

S&R Associates represented MiddleGround Capital - Lexology

Aug 11, 2026

ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - Stocktwits

Aug 11, 2026

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Public Opinion

Aug 11, 2026

Aug 10, 2026

EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal - Yahoo Finance

Aug 10, 2026

Form 8K Aspire Biopharma Holdings Inc For: 10 August By Investing.com - Investing.com Nigeria

Aug 10, 2026

Aspire Biopharma Completes $30 Million Acquisition of Dura Driver Control Systems - citybiz

Aug 10, 2026

Aspire Biopharma Closes Acquisition of FireFish Units Under Asset and Equity Purchase Agreement - TradingView

Aug 10, 2026

Aspire Biopharma completes $30M automotive supplier acquisition By Investing.com - Investing.com Australia

Aug 10, 2026

Aspire Biopharma completes $30M automotive supplier acquisition - Investing.com

Aug 10, 2026

Aug 09, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - The Northwest Florida Daily News

Aug 09, 2026

Aug 08, 2026

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements - news.futunn.com

Aug 08, 2026

Aug 05, 2026

Aspire Biopharma (ASBP) Climbs 3.3% to $7.27, Approaches Key Resistance at $7.63Sector Sentiment - vinanet.vn

Aug 05, 2026

Aug 03, 2026

Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire

Aug 03, 2026

Jul 31, 2026